The identity and forms of activating ligands for ion channels are fundamental to their physiological roles in rapid electrical signaling. P2X receptor channels are ATP-activated cation channels that serve important roles in sensory signaling and inflammation, yet the active forms of the nucleotide are unknown. , and demonstrate that both restraining mechanisms can be disengaged in heteromeric channels to form fast and sensitive ATP signaling pathways in sensory neurons. magnesium ATP | magnesium regulation S even subtypes of P2X receptors have been identified in mammals that can form either homomeric (P2X1, P2X2, P2X3, P2X4, P2X5, P2X7) or heteromeric (P2X1/2, P2X1/4, P2X1/5, P2X2/3, P2X2/5, P2X2/6, P2X4/6, and possibly, P2X4/7) channels (1-8). These subtypes of P2X receptors have distinct gating properties, pharmacology, and cellular distributions. P2X1 and P2X3 receptors desensitize within a few hundred milliseconds when opened by ATP, and their distributions are restricted to either smooth muscle cells and platelets (P2X1) or a subset of sensory neurons (P2X3) (1, (9) (10) (11) (12) (13) (14) . P2X2 and P2X4 receptors exhibit slow desensitization during prolonged ATP application, and these receptors are the most abundant subtypes in the central nervous system (15). P2X2 subunits also express in a subset of sensory neurons; however, in these cells they only form heteromeric channels with P2X3 subunits (12, 16, 17) . In sensory neurons, P2X3 homomeric channels together with P2X2/3 heteromeric channels play important roles in mediating the primary sensory effects of ATP, and knock-out animals with either P2X3 deletion or P2X2 and P2X3 double-deletions have revealed critical roles in taste, pain, oxygen sensing, and bladder filling (17-20).
The identity and forms of activating ligands for ion channels are fundamental to their physiological roles in rapid electrical signaling. P2X receptor channels are ATP-activated cation channels that serve important roles in sensory signaling and inflammation, yet the active forms of the nucleotide are unknown. In physiological solutions, ATP is ionized and primarily found in complex with Mg 2+ .
Here we investigated the active forms of ATP and found that the action of MgATP 2− and ATP 4− differs between subtypes of P2X receptors. The slowly desensitizing P2X2 receptor can be activated by free ATP, but MgATP 2− promotes opening with very low efficacy. In contrast, both free ATP and MgATP 2− robustly open the rapidly desensitizing P2X3 subtype. A further distinction between these two subtypes is the ability of Mg 2+ to regulate P2X3 through a distinct allosteric mechanism. Importantly, heteromeric P2X2/3 channels present in sensory neurons exhibit a hybrid phenotype, characterized by robust activation by MgATP 2− and weak regulation by Mg 2+ . These results reveal the existence of two classes of homomeric P2X receptors with differential sensitivity to MgATP , and demonstrate that both restraining mechanisms can be disengaged in heteromeric channels to form fast and sensitive ATP signaling pathways in sensory neurons.
magnesium ATP | magnesium regulation S even subtypes of P2X receptors have been identified in mammals that can form either homomeric (P2X1, P2X2, P2X3, P2X4, P2X5, P2X7) or heteromeric (P2X1/2, P2X1/4, P2X1/5, P2X2/3, P2X2/5, P2X2/6, P2X4/6, and possibly, P2X4/7) channels (1) (2) (3) (4) (5) (6) (7) (8) . These subtypes of P2X receptors have distinct gating properties, pharmacology, and cellular distributions. P2X1 and P2X3 receptors desensitize within a few hundred milliseconds when opened by ATP, and their distributions are restricted to either smooth muscle cells and platelets (P2X1) or a subset of sensory neurons (P2X3) (1, (9) (10) (11) (12) (13) (14) . P2X2 and P2X4 receptors exhibit slow desensitization during prolonged ATP application, and these receptors are the most abundant subtypes in the central nervous system (15) . P2X2 subunits also express in a subset of sensory neurons; however, in these cells they only form heteromeric channels with P2X3 subunits (12, 16, 17) . In sensory neurons, P2X3 homomeric channels together with P2X2/3 heteromeric channels play important roles in mediating the primary sensory effects of ATP, and knock-out animals with either P2X3 deletion or P2X2 and P2X3 double-deletions have revealed critical roles in taste, pain, oxygen sensing, and bladder filling (17) (18) (19) (20) .
A long-standing conundrum in P2X receptor-mediated signaling concerns the forms of ATP that activate these channels. In neutral solutions, ATP is ionized and exists mostly as free ATP (ATP 4− ), an efficient chelator of divalent cations such as Mg 2+ , and to a lesser extent Ca 2+ (21) . In extracellular biological compartments, such as the synaptic cleft, Ca 2+ and Mg 2+ are present in the millimolar range, and therefore only a relatively small fraction of ATP released from vesicles is present in the free form. Although a range of important studies have explored the regulatory effects of Ca 2+ and Mg 2+ on P2X receptor channels (22) (23) (24) (25) (26) (27) (28) (29) (30) , the essential question of which forms of ATP serve as agonists remains unresolved. Several previous studies have reported that P2X2, P2X7, and the native P2X receptors in cilia are activated by ATP in solutions containing low concentrations of divalent cations, and that the addition of divalent cations shifts the concentration dependence for activation of the channels to higher ATP concentrations, suggesting that either ATP 4− is the most active form of ATP or that divalent cations regulate those subtypes through allosteric mechanisms (27, (30) (31) (32) (33) (34) (35) (36) . In the present study, we investigated the form(s) of ATP that serve as agonists for a range of subtypes of P2X receptor channels. Our primary focus was to determine whether ATP 4− or MgATP 2− are the principal agonists and to explore whether Mg 2+ might serve specific regulatory roles. Our results demonstrate that the action of MgATP 2− and ATP 4− differ between subtypes of P2X receptors, and reveal that heteromeric channels can have unique hybrid phenotypes, findings that will be crucial for understanding the physiological functions of these channels in both the peripheral and central nervous systems.
Results

ATP
4− Activates All Subtypes of Homomeric P2X Receptor Channels.
We began by establishing whether ATP 4− can activate each subtype of P2X receptor that can be heterologously expressed as a homomeric channel. To test for activation by ATP 4− , we used the patch-clamp recording technique to record ATP-activated currents when applying the nucleotide in the presence of 10 mM EDTA to remove contaminating divalent ions that are present in aqueous solutions. Because divalent ions stabilize seals between electrode glass and cell membranes that are required for patchclamp recordings (37, 38) , we first established GΩ seals with 0.5 mM Mg 2+ and 2 mM Ca 2+ in the extracellular solution, and only
Significance
ATP is an important extracellular signal that activates P2X receptor channels. Although a large fraction of ATP is bound to divalent cations in vivo, the forms of ATP that activate P2X receptors are unknown. Here we show how the activity of homomeric P2X receptors is tuned by Mg 2+ in some subtypes by preventing activation by free ATP, and in others by binding to a distinct regulatory site. We also find that both regulatory mechanisms are disengaged in heteromeric channels to form a sensitive ATP signaling pathway. These fundamental properties of P2X receptors will be valuable for investigating their physiological functions. studied cells further if the seal was exceptionally tight (>10 GΩ resistance) and stable for 5 min after switching to a 10-mM EDTA solution. Using this approach to study HEK cells transfected with P2X receptor cDNA, we observed that 300 μM ATP evokes currents with kinetic properties resembling those that have been reported in solutions with divalent cations (1) (Fig. 1A) . Both P2X1 and P2X3 receptors rapidly desensitized in response to ATP 4− , whereas the others exhibited a more slowly desensitizing phenotype. For P2X1, P2X2, P2X3, and P2X4 receptors, the EC 50 concentrations for ATP activation in the divalent-free solution were between 1 and 2 μM (Fig. 1B) . In agreement with previous studies, the ATP-activated P2X5 currents are typically very small, and P2X7 receptors activate slowly and with low affinity for ATP, limitations that precluded further experiments with these subtypes (34, 39) . We also did not study P2X6 receptors because they are difficult to express as homomeric channels (40, 41 In the case of P2X1 and P2X3 receptor channels, >90% of maximum activation was observed in the presence of 5 mM MgCl 2 ( Fig. 2 A and B) , suggesting that MgATP 2− is an agonist for these two subtypes. However, in the case of P2X2, this Mg-ATP solution activated very little steady-state current (Fig. 2C) , and for P2X4, the fractional activation was ∼10% (Fig. 2D) . Notably, upon exchanging the test extracellular solution containing both Mg 2+ and ATP with the control solution containing EDTA, we detected a rapid increase in the inward current for cells expressing either P2X2 or P2X4, which we termed a resurgent current ( Fig. 2 C (Fig. 1B) . As the concentration of Mg 2+ and ATP increase, we observed steady-state currents that were consistently small when the test solution was applied; however, the amplitude of I R increased along with the concentration of MgATP 2− (Fig. 3 A and B) , in line with the idea that MgATP 2− can bind to P2X2 receptors and that this complex is not effective at opening the channel.
To confirm these results, we performed additional experiments using a piezoelectric-driven solution exchange system that can routinely achieve solution exchange within 4 ms. elicited only steady-state current (without a measurable I R ) that is 13 ± 2% (n = 6) of maximum current activated by saturating concentration of ATP 4− (Fig. 3C ). In contrast, the solution containing 0.4 μM ATP 4− and 10 μM MgATP 2− activates a smaller steady-state current, which is only 6 ± 1% (n = 6) of the maximum current, and when Mg 2+ and ATP are removed I R is now observed (Fig. 3C) . All of these observations are consistent with the idea that ATP 4− binds with higher affinity compared with MgATP 2− , and that the former promotes channel opening much more effectively. The activation kinetics for the steady-state current activated by 0.4 μM ATP 4− and 0.6 μM MgATP 2− are slower than that activated by 0.4 μM ATP 4− and 10 μM MgATP 2− (Fig. 3D) , which is consistent with the notion that both ATP 4− and MgATP 2− bind to the receptor. We also investigated the amplitude of I R as a function of how long MgATP 2− is applied to the external solution, and determined that 100 ms is sufficient for I R to reach its maximum (Fig. 3E) ; in essence, this is an inhibitory mechanism by which Mg 2+ would appear to behave as a simple competitive antagonist. To investigate this possibility, we obtained concentration-response relations for ATP activation of P2X2 over a range of Mg 2+ concentrations and used Schild analysis to determine whether the effects of Mg 2+ obey a simple competitive mechanism (42) . Because P2X receptors might be blocked by Mg 2+ , we determined the range of MgCl 2 concentrations over which block was not significant. We did not observe any obvious voltage dependence under conditions where Mg 2+ produced robust inhibition of the P2X2 receptor channel (Fig.  4A ), arguing against pore block as the primary mechanism of inhibition. In experiments in which the channels are activated with 1 mM ATP to ensure that ATP 4− is saturating in the presence of all tested Mg 2+ concentrations, increasing MgCl 2 from 0.1 mM to 12.5 mM has only modest effects on P2X2 currents (Fig. 4B) . Next, we constructed concentration-response relations for ATP activation in solutions with four different concentrations of MgCl 2 (0.1, 0.5, 2.5, and 12.5 mM), and observed that although the relations are similar in shape, they shift to higher ATP concentrations as the concentration of Mg 2+ increases (Fig. 4C ). The slope of the Schild plot for the EC 50 concentrations obtained in different concentrations of Mg 2+ is 1.1 ± 0.1 (Fig. 4D) . Between ATP pulses, cells were perfused with divalent-free solution. To estimate rundown, 10 μM ATP was applied twice at 90-s intervals in the divalent-free solution, and all subsequent ATP applications were given at 90-s intervals. Similar experiments were repeated on 3-4 different cells. (Right) Summary of normalized currents in response to each ATP pulse. Numbering indicates the sequence of ATP applications from first (1) to last (4). P2X1-P2X3 subtypes were studied with conventional whole-cell recording, and P2X4 was studied with the perforated-patch configuration. I R observed in P2X2 and P2X4 are indicated with an asterisk. (E and F) Enlarged views of I R for P2X2 (E) or P2X4 (F). Scale bars on the left show the amplitude of currents normalized to that activated by 10 μM ATP 4− .
equilibrate with the receptor (26) . (Fig. 5A) . Even more pronounced inhibition by Mg 2+ was observed for P2X1 receptors, whereas relatively modest inhibition was evident for P2X2 or P2X4 receptors (Fig. S1 ). Next we constructed concentration-response relations for ATP activation of P2X3 receptors in the continuous presence of 0.1, 0.5, or 2.5 mM MgCl 2 (Fig. 5B) , and observed that currents activated by saturating concentrations of ATP decrease as the concentration of Mg 2+ increases, and that near maximal inhibition is obtained at submillimolar Mg 2+ concentrations. In contrast to the inhibitory mechanism discussed above for P2X2 receptors, Mg 2+ inhibition of P2X3 cannot be overcome by increasing the concentration of ATP, suggesting a distinct regulatory mechanism. Interestingly, the concentrationresponse relationship is detectably shifted toward lower ATP concentrations in the presence of 0.1 mM MgCl 2 , suggesting that MgATP 2− has either a higher binding affinity or efficacy for activating P2X3 receptors compared with ATP 4− . To identify the binding site for Mg 2+ in P2X3 receptors, we examined the Gd 3+ sites identified crystallographically in zebrafish P2X4 (zfP2X4) (44) . Gd 3+ is commonly used to localize putative divalent cation binding sites in X-ray structures of proteins, and two types of Gd 3+ binding sites have been identified in the closed state zfP2X4 crystal structure-a singular site at the threefold axis within the central chamber of the extracellular domain, and three identical peripheral sites within that domain (Fig. 5 C and G) (44) . As shown in that structure, E98 from each of the three zfP2X4 subunits form a single binding site in the central chamber, and D184 and N187 from each subunit form the three sites at the periphery of the trimeric receptor (Fig. S2) . We mutated E167 and N170 in P2X3, positions equivalent to D184 and N187 in the peripheral Gd 3+ sites of zfP2X4, and T87 in P2X3, a residue located within the central chamber nearby E98 in zfP2X4, and investigated whether preincubation with 1 mM MgCl 2 would affect the channel currents activated by saturating concentrations of ATP (Fig. 5 C-G) . Although Mg 2+ inhibition was unaffected in the E167A and N170A mutants in the peripheral sites (Fig. 5 C, F , and G), inhibition was greatly attenuated in the case of the T87A mutant in the central chamber (Fig. 5 C-F) . We also constructed concentration-responses relations for ATP activation in the presence of either 0.5 or 2.5 mM MgCl 2 (Fig. 5E) for the T87A mutant. No inhibition was observed at 0.5 mM MgCl 2 , compared with nearly maximal inhibition at that concentration for WT P2X3. Indeed, at this concentration of MgCl 2, we observed a modest shift of the concentration-response relationship for activation by ATP to lower ATP concentrations, consistent with MgATP 2− having a higher affinity or efficacy for the P2X3 receptor. At 2.5 mM, MgCl 2 inhibited the maximum activation by 30 ± 1%, which is significantly reduced compare with the 73 ± 1% To rule out the possibility that Mg 2+ also binds to the central chamber in the P2X2 receptor channel or to the peripheral sites to produce inhibition, we looked for residues in P2X2 that might be related to those forming the two types of Gd 3+ sites in zfP2X4. The Glu in the central cavity and the Asp in the periphery are not conserved in rP2X2, but we identified nearby residues that might play similar roles. We mutated E91 and D315 (rP2X2) in the central cavity, and M179 plus N182 at the peripheral site to Ala, and tested if Mg-ATP solution could activate these mutant channels (Fig. S3) . Although the concentration dependence for activation by ATP 4− was altered to varying degrees in these mutant channels (in particular for D315A mutant), all were weakly activated in the Mg-ATP solution and display I R when removing Mg 2+ and ATP (Fig. S3 ). . In the X-ray structure of the zfP2X4 receptor, the ATP binding site is formed by a pocket at the interface between adjacent subunits (45) . For P2X3 receptors, inhibition appears to result from Mg 2+ binding to the central chamber formed at the interface between all three subunits; this raises an intriguing possibility that both inhibitory mechanisms might be altered in P2X2/3 heterotrimeric receptors, a specific combination of subunits involved in forming P2X receptor channels in sensory neurons. Heteromeric P2X2/3 receptor channels exhibit slow desensitization similar to P2X2, yet can be activated by αβ-methylene ATP (αβ-MeATP), an ATP analog that activates P2X3 with much higher affinity and efficacy compared with P2X2, together providing the means for distinguishing P2X2/3 heteromeric channels from P2X2 or P2X3 homomeric channels (12, 46) . When P2X2 and P2X3 receptors are coexpressed in HEK cells, we observed that 10 μM ATP in divalent-free solution only activates slow-desensitizing currents that are similar to those activated by αβ-MeATP (Fig. 6 A and B) , suggesting that under these expression conditions, heteromeric P2X2/3 channels are more abundant than homomeric P2X2 or P2X3 channels. Application of 10 μM ATP with 5 mM MgCl 2 (a solution that contains ∼0.2 μM ATP 4− and ∼9.8 μM MgATP 2− ) produces activation of the slowly desensitizing current that is much larger than that activated by 0.2 μM ATP 4− (Fig. 6A) . This current could not arise from P2X3 receptors because it desensitizes slowly, and it could not arise from P2X2 receptors because that subtype is not efficiently activated by MgATP 2− (Fig. 2 ). These results demonstrate that heterologously expressed P2X2/3 heteromeric channels can be activated by both ATP 4− and MgATP 2− . To investigate whether Mg 2+ inhibits P2X2/3 channels through the central chamber site identified in P2X3 receptors, we tested whether currents activated by saturating concentrations of ATP are inhibited by 1 mM MgCl 2 when preequilibrated for 90 s (Fig. 6B) , the same protocol we used with homomeric P2X3 channels. The results show that P2X2/3 channel currents activated by 100 μM ATP are not detectably inhibited by Mg 2+ , suggesting that central chamber Mg 2+ site is not robustly engaged in these heteromeric channels.
To examine whether the properties of P2X2/3 heteromeric channels expressed in native dorsal root ganglion (DRG) neurons are similar to those in HEK cells, we initially applied ATP in a physiological solution containing divalent cations and observed detectable currents in 22 of 38 neurons tested. The responsive neurons exhibited three types of currents, resembling those of P2X3 only ( Fig. 6C, Left; four cells), P2X3 together with P2X2/3 ( Fig. 6C , Center; three cells), or P2X2/3 only ( Fig. 6C , Right; 15 cells), consistent with previous studies (16, 47) . The neurons that were nonresponsive to ATP in solution containing divalent cations did not respond to ATP in divalent-free solution, suggesting that homomeric P2X2 receptors are not expressed in these cells. Also consistent with previous results, the slowly desensitizing P2X receptors in DRG neurons could be activated by αβ-MeATP, further suggesting that they are P2X2/3 heteromeric 4− concentration in these solutions is 9.6 μM (12.5 mM MgCl 2 plus 1 mM ATP). All currents were recorded from the same cell. The amplitudes of ATP-activated currents for the second through sixth ATP applications were 99 ± 1%, 94 ± 2%, 95 ± 2%, 95 ± 4%, and 88 ± 5% of the first application (n = 4). (C) Doseresponse curves for ATP activation of P2X2 receptors obtained in EDTA solutions and in solutions with 2.5 mM MgCl 2 . Each point is the average ± SEM of four measurements. The Hill equation was fit to the data, and the EC 50 and (n) are 1.4 ± 0.1 μM and (1.3 ± 0.1) for that in EDTA solution and 17.9 ± 0.9 μM and (1.9 ± 0.2) for that in 2. channels (Fig. 6D) . In this latter class of cells, 0.2 μM ATP 4− only activated small currents that are <10% of those activated by 10 μM ATP 4− , and a solution containing 0.2 μM ATP 4− and 9.8 μM MgATP 2− activated currents that are comparable to those activated by 10 μM ATP 4− , indicating that P2X2/3 in DRG neurons can be activated by MgATP 2− (Fig. 6D ).
Discussion
The objective of the present study was to determine which forms of ATP can serve as agonists for different subtypes of P2X receptor channels and to explore whether Mg 2+ serves any regulatory roles. Collectively, our results demonstrate that ATP in its free ionic form is an active ligand for all subtypes of homomeric P2X receptors, and that the activity of P2X1-P2X4 receptors are inhibited by the presence of physiological concentrations of Mg 2+ (Table S1) Macroscopic ATP-activated currents were measured using a holding voltage of −60 mV. To estimate rundown, 300 μM ATP was applied twice in EDTA solution with a 90-s interval between repeated ATP applications. Five seconds after the second ATP pulse, the external solution was switched to one containing 1 mM MgCl 2 , and ATP was applied again 90 s later to estimate the effects of MgCl 2 . In control experiments in divalent-free solution, the rundown to repeated ATP applications was estimated to be 7 ± 4%. Compared with currents in divalent-free solutions, the currents in solutions with 1 mM MgCl 2 are 66 ± 7% smaller (n = 4). (B) Dose-response curves for ATP activation of P2X3 WT receptors in the presence of EDTA or different concentrations of MgCl 2 . Each point is the average ± SEM of 3-4 measurements. The Hill equation was fit to the data, and the EC 50 and (n) are 2.0 ± 0.7 μM and (1.1 ± 0.3) for that in EDTA solution, 0.6 ± 0.1 μM and (1.1 ± 0.2) for that in 0.1 mM MgCl 2 , 0.7 ± 0.1 μM and (1.1 ± 0.2) for that in 0.5 mM MgCl 2 , and 0.6 ± 0.1 μM and (1.2 ± 0.2) for that in 2.5 mM MgCl 2 . (C) Sequence alignment of two extracellular segments of P2X receptors. (D) Effects of 1 mM MgCl 2 on P2X3 T87A mutant receptors activated with 300 μM ATP. Experimental protocol is the same as that shown in A. In control experiments in divalent-free solution, the rundown to repeated ATP applications was estimated to be 5 ± 3%. Compared with currents in divalent-free solutions, the currents in solutions with 1 mM MgCl 2 are 11 ± 5% smaller (n = 3). (E) P2X3 T87A mutant channel dose-response curves for ATP activation in the presence of EDTA or different concentrations of MgCl 2 . Each point is the average ± SEM of 3-4 measurements. The Hill equation was used to fit the data, and the EC 50 and (n) are 1.1 ± 0.2 μM and (1.3 ± 0.2) for that in EDTA solution, 0.7 ± 0.1 μM and (1.1 ± 0.1) for that in 0.5 mM MgCl 2 , and 0.9 ± 0.3 and (1.1 ± 0.3) for that in 2.5 mM MgCl 2 . (F) Summary of the effect of 1 mM MgCl 2 on P2X3 WT and mutant channels. The experiments were carried out in the same way as that shown in A and E. Currents after 1 mM MgCl 2 application were normalized to the currents activated by 300 μM ATP that there are two classes of P2X receptors that differ in the forms of ATP that can serve as agonists (Table S1 ). Because Ca 2+ can also chelate ATP 4− , and is abundant in physiological solutions, it is interesting to consider whether it would behave similarly to Mg
2+
. Although quantitative comparison with Mg 2+ is complicated by the fact that Ca 2+ permeates P2X receptor channels to different degrees, and thus can change the unitary conductance, we obtained qualitatively comparable results with Ca 2+ that are consistent with the general idea that divalent-bound ATP can serve as an agonist for P2X3, but not P2X2 receptor channels (Fig. S4) .
The structural differences between the two classes of ATP binding sites in P2X receptor channels are likely subtle; however, it is interesting that their sensitivities to MgATP 2− are paralleled by other pharmacological distinctions. P2X1 and P2X3 receptor channels can be activated by αβ-MeATP with an EC 50 concentration about 1 μM, but P2X2 and P2X4 receptor channels can only partially be activated by 100 μM αβ-MeATP. In addition, P2X1 and P2X3 receptors are inhibited by nanomolar concentrations of trinitrophenyl-ATP, whereas P2X2 and P2X4 are much less sensitive (8, 46, 48) . It appears that those receptors that can trigger opening with Mg 2+ bound to ATP in the agonist binding pockets also have room for the larger agonists and antagonists. These pharmacological distinctions imply that the agonist binding site of P2X4 is most similar to P2X2, raising the possibility that the mechanism of Mg 2+ inhibition is similar for these two subtypes. We observed resurgent currents for P2X4 that resemble those of P2X2 (Fig. 2) , and the apparent affinities of ATP for P2X2 and P2X4 receptors are similar in physiological solutions containing divalent ions, and lower than observed for P2X1 and P2X3 receptors (1, 2). In addition, Mg 2+ produces only modest inhibition of P2X4 in the presence of high concentrations of ATP (Fig. S2) , demonstrating that much of the Mg 2+ inhibition can be overcome by increasing the concentration of ATP. Thus, the available evidence is most consistent with the idea that both P2X2 and P2X4 are most efficiently activated by ATP 4− . One important implication of this selective activation of P2X2 and P2X4 receptors by the physiologically scarce form of ATP is that these subtypes will require substantially higher concentration of released ATP for efficient signaling to occur when they are expressed as homomeric receptors. Perhaps in these instances, P2X2 and P2X4 receptors primarily serve to detect high concentrations of ATP, as might be expected with repetitive ATP release or with inflammation where cells are dying and releasing cytoplasmic ATP.
In contrast, P2X1 and P2X3 receptor channels can be activated by lower concentrations of ATP in the presence of Mg 2+ because MgATP 2− is an effective agonist for these channels ( Fig.  2 A and B) . In the case of P2X3 receptors, we observed that the concentration dependence for activation by ATP was shifted to lower ATP concentrations in the presence of low Mg 2+ concentrations, suggesting that MgATP 2− has either higher affinity or efficacy compared with ATP 4− . However, both P2X1 and P2X3 receptors are partially inhibited by Mg 2+ through a distinct mechanism that likely involves binding of the metal to the central chamber in the extracellular domain (Fig. 5) . In the X-ray structure of the apo zfP2X4 receptor, Gd 3+ binds to the central chamber and is coordinated intimately by E98 (Fig. S2A) . Interestingly, in both apo and ATP-bound structures solved in the absence of Gd 3+ , the side chain of E98 swings away from the central axis (Fig. S2 B and C) , demonstrating that Gd 3+ binding induces a reorientation of the E98 side chain. In a P2X3 homology model made from apo zfP2X4, the critical threonine (Thr) we identified (T87) is located within the central chamber and its side chain projects toward the threefold axis of symmetry (Fig. 5G) . The hydroxyl moieties in this homology model are positioned within 7 Å of each other, compatible with a role in coordinating Mg 2+ (Fig. 5G) . In contrast, the expansion of the central chamber that occurs in the open-state zfP2X4 structure (and open P2X3 homology model) would be less compatible with stable coordination of Mg 2+ (Fig. 5G and Fig. S2) (45, 49) . Thus, we speculate that the Mg 2+ inhibits both P2X1 and P2X3 receptors by stabilizing the extracellular domain in a nonconductive conformation. One possibility is that Mg 2+ inhibits P2X3 receptors by stabilizing a desensitized state of the receptor, as previously proposed (26) .
One intriguing common feature of the mechanisms for Mg 2+ inhibition of homomeric P2X2 and P2X3 receptors is that the sites of Mg 2+ action are localized to subunit interfaces. In the case of P2X2 receptors, Mg 2+ binds to ATP in the agonist binding pocket formed by adjacent subunits, and in the case of P2X3, Mg 2+ likely binds to the central chamber at the threefold axis. P2X2 and P2X3 receptors have been demonstrated to form heteromeric channels in sensory neurons, and in this instance the heteromeric channels contain one P2X2 subunit and two P2X3 subunits (50, 51) . Thus, the Mg 2+ regulatory site in the central chamber would be expected to be weakened because it is missing one of three Thr residues. Similarly, none of the three agonist binding sites would be formed purely by P2X2 subunits; two would be formed at the interface between P2X2 and P2X3 subunits, and one would be constructed at a purely P2X3/P2X3 interface. In particular for heteromeric P2X2/3 receptors, it is not surprising that these heteromeric channels would be robustly activated by MgATP 2− given that all three agonist binding sites have contributions from P2X3 subunits.
The key discoveries described here are that (i) the active forms of ATP are not the same for different subtypes of P2X receptors, with P2X2 and likely P2X4 requiring free ATP, whereas P2X1 and P2X3 are also sensitive to MgATP binding to the central chamber; and (iii) both of these mechanisms that constrain activation of the receptor can be disengaged when heteromeric receptors form. These findings likely have a range of important implications for understanding the physiological functions of P2X receptor channels in both the central and peripheral nervous systems. In particular, the slowly desensitizing homomeric P2X2 and P2X4 receptor channels would be well-suited for signaling roles when the concentration of extracellular ATP is sufficiently high, whereas the rapidly desensitizing homomeric P2X1 and P2X3 receptors would be more sensitive to lower concentrations of ATP. However, heteromerization of these two classes of P2X receptors channels allows the creation of hybrid channels that are sensitive to MgATP 2− , slowly desensitizing and relatively insensitive to Mg 2+ inhibition involving the central chamber. It will be fascinating to explore whether the present studies with heteromeric P2X2/3 receptor channels can be generalized to other complexes to provide a common logic for heteromerization. Our collective results would predict similar hybrid behavior for previously documented heteromeric P2X1/2 and P2X1/4 receptor channels, and it will be exciting to investigate the role of the P2X6 subunits when it forms heteromeric channels with P2X2 and P2X4, all three of which are widely expressed within the central nervous system (15, 26, (52) (53) (54) (55) .
Materials and Methods
Channel Constructs. Human P2X1 (hP2X1) in pcDNA3 was generously provided by Richard Evans (University of Leicester, Leicester, United Kingdom). rP2X2 in pcDNA1 was generously provided by David Julius (University of California, San Francisco, San Francisco). hP2X2 and hP2X3 in pCMV6-XL4 were purchased from OriGENE. rP2X4 and rP2X7 in pcDNA3 were generously provided by Florentina Soto (Washington University in St. Louis, St. Louis). rP2X5 was generously provided by Alan North (University of Manchester, Manchester, United Kingdom) and was cloned into pcDNA1. rP2X2 was used in most experiments; however, the key results shown in Figs. 2C and 6A were also repeated with hP2X2 and similar results were obtained. rP2X3 and hP2X3 share 94% sequence identity, and none of the minor differences localize to the ATP binding sites observed in zfP2X4, suggesting that these two species will share the properties described here for hP2X3.
Cell Culture and Transfection. HEK cells were cultured in DMEM supplemented with 10% (vol/vol) FBS and 10 mg/L gentamicin. All cell culture reagents were obtained from GIBCO. Trypsin-treated HEK293 cells were seeded onto glass coverslips in six-well plates 1 d before transfection and placed in a 37°C incubator with 95% air and 5% CO 2 . Transfections were performed using FuGENE6 Transfection Reagent (Roche Applied Science). P2X receptors were cotransfected with a GFP cDNA construct in pGreen-Lantern (Invitrogen) at a ratio of 2:1. Cells were used for whole-cell recording 18-30 h after transfection.
DRG Preparation. Isolated DRG neurons were prepared from 7-to 14-d-old rats using procedures similar to what has been previously described (56) . After anesthetizing rats with isoflurane and decapitation, segments of the spinal cord (thoracic and lumbar segments) were removed and placed in a cold Ca -free HBSS containing 0.1 U/mL collagenase and 0.8 U/mL Dispase (Roche Applied Science), and incubated at 37°C for 20 min. After two successive incubations in enzymes, ganglia were transferred into Leibovitz's L-15 medium (Invitrogen) supplemented with 10% FCS, 5 mM Hepes, and 50 ng/mL NGF (Invitrogen). Individual cells were dispersed by mechanical trituration using a fire-polished Pasteur pipette and plated on poly-D-lysine/ laminin-coated glass coverslips (BD Biosciences). Cells were incubated in a 37°C incubator with 95% air and 5% CO 2 for 3 h, after which cells were stored at room temperature and used for patch-clamping within 24 h.
Electrophysiology. Standard whole-cell patch-clamp recording was used to record most P2X receptor channel currents from transiently transfected HEK293 cells and isolated DRG neurons. Perforated patch-clamp recording was used to record P2X4 receptor channel currents to minimize the rundown in response to repeated ATP applications (57) . Membrane currents were recorded under voltage clamp using an Axopatch 200B patch-clamp amplifier (Axon Instruments, Inc.) and digitized online using a Digidata 1322A interface board and pCLAMP 9.2 software (Axon Instruments, Inc.). Currents were filtered at 2 kHz using eight-pole Bessel filters, and digitized at 5 or 10 kHz. The pipette solution for standard whole-cell recording on HEK cells contained (in mM) 140 NaCl, 10 EGTA, and 10 Hepes, adjusted to pH 7.0 with NaOH. The pipette solution for standard whole-cell recording on DRG neurons contained (in mM) 65 CsCl, 65 CsF, 10 NaCl, 2 MgCl 2 , 10 EGTA, 10 Hepes, 14 Tris·creatine PO 4 , 4 Mg-ATP, and 0.3 Na-GTP (pH 7.2) with CsOH. The pipette solution for perforated patch-clamp recording on HEK cells contained (in mM) 65 K 2 SO 4 , 10 NaCl, 1 CaCl 2 , 1 MgCl 2 , 10 Hepes (pH 7.2) with KOH. The divalent-free extracellular solution contained (in mM) 140 NaCl, 10 EDTA, and 10 Hepes, adjusted to pH 7.3 with NaOH. Assuming that divalent ion contaminations from reagents and water is less than 1 μM, any possible free divalent cations in the 10 mM EDTA solution would be less than 0.5 nM. , and ATP 4− in solutions with different concentrations of MgCl 2 and ATP. Recording solutions were adjusted to the correct pH after adding MgCl 2 and ATP. Solution exchange was achieved using either the Rapid Solution Changer RSC-200 (BioLogic), which has the capacity of switching between nine solutions, or a Piezo-driven system (AutoMate Scientific), which can change two solutions within 1 to 4 ms, depending on the size of the cell.
Data Analysis. To generate the dose-response relationship, a reference concentration of ATP was given every time before a test concentration was applied, as previously described (31) . The Hill equation was fit to the data according to
Á , where I is the normalized current at a given concentration of ATP, I max is the maximum normalized current, EC 50 is the concentration of ATP ([ATP]) producing half-maximal currents, and n is the Hill coefficient.
